These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 10422751
21. The role of the small airways in the clinical expression of asthma in adults. Farah CS, King GG, Brown NJ, Downie SR, Kermode JA, Hardaker KM, Peters MJ, Berend N, Salome CM. J Allergy Clin Immunol; 2012 Feb; 129(2):381-7, 387.e1. PubMed ID: 22188824 [Abstract] [Full Text] [Related]
22. Targeting the small airways asthma phenotype: if we can reach it, should we treat it? Lipworth B. Ann Allergy Asthma Immunol; 2013 Apr; 110(4):233-9. PubMed ID: 23535085 [Abstract] [Full Text] [Related]
23. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Dupont LJ, Rochette F, Demedts MG, Verleden GM. Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):894-8. PubMed ID: 9517608 [Abstract] [Full Text] [Related]
24. Clinical implications of airway inflammation in mild intermittent asthma. van den Toorn LM. Ann Allergy Asthma Immunol; 2004 Jun; 92(6):589-94; quiz 595-7, 658. PubMed ID: 15237759 [Abstract] [Full Text] [Related]
25. Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma. Wang K, Liu CT, Wu YH, Feng YL, Bai HL. Adv Ther; 2008 Apr; 25(4):342-54. PubMed ID: 18421428 [Abstract] [Full Text] [Related]
27. Are we overlooking persistent small airways dysfunction in community-managed asthma? Anderson WJ, Zajda E, Lipworth BJ. Ann Allergy Asthma Immunol; 2012 Sep; 109(3):185-189.e2. PubMed ID: 22920073 [Abstract] [Full Text] [Related]
28. Overcoming gaps in the management of asthma in older patients: new insights. Barua P, O'Mahony MS. Drugs Aging; 2005 Sep; 22(12):1029-59. PubMed ID: 16363886 [Abstract] [Full Text] [Related]
34. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma. Bjermer L, Diamant Z. Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707 [Abstract] [Full Text] [Related]
35. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM. Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005533. PubMed ID: 16235409 [Abstract] [Full Text] [Related]
36. The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1? Scichilone N, Battaglia S, Olivieri D, Bellia V. Allergy; 2009 Nov 19; 64(11):1563-9. PubMed ID: 19712119 [Abstract] [Full Text] [Related]
37. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Ducharme FM, Lasserson TJ, Cates CJ. Cochrane Database Syst Rev; 2006 Oct 18; (4):CD003137. PubMed ID: 17054161 [Abstract] [Full Text] [Related]
38. What are the alternatives to increasing inhaled corticosteroids for the long term control of asthma? Flood-Page P, Barnes NC. BioDrugs; 2001 Oct 18; 15(3):185-98. PubMed ID: 11437684 [Abstract] [Full Text] [Related]